OakChart

Nature's Sunshine Products Inc

NATRConsumer Defensive·Packaged Foods·USA·Micro·NASD·Nov 10 • 3:59 PM ET

10.930.00 (0.00%)
2026-11-11 15:18 CET
Market cap
189.40 USD m
Revenue, TTM
480.29 USD m
Net income, TTM
14.65 USD m
Free cash flow, TTM
10.51 USD m
EPS diluted, TTM
0.81
P/E
13.44
Compare

Price

NATR against its 20, 50 and 200-day averages
2050200beatmiss
10.0015.0020.0025.00798K1.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NATRclose 10.9320-day 12.0850-day 12.69200-day 20.1110.93

61.2% under 28.14 on 2 Mar 2026. Last 15 sessions, 38.0% high to low

Profile

NATR
52-week range, 8% of the way up
9.3828.14

Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. Its product lines include general health, immune, cardiovascular, digestive, personal care, and weight management. It operates through the following geographical segments: Asia, Europe, North America, and Latin America and Other. The company was founded by Eugene L. Hughes, Kristine F. Hughes, and Pauline Hughes-Francis in 1972 and is headquartered in Lehi, UT.

IndexRUT
Employees806
IPOMar 17, 1980
Beta0.83
ATR, 14d0.65
Rel volume0.00
Short float6.53%
Insider own6.16%
Inst own94.33%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap189.40M
Enterprise Value121.05M
Income14.65M
Sales480.29M
Book/sh9.87
Cash/sh5.16
Dividend Est.-
Dividend TTM-
Dividend Ex-DateMar 26, 2021
Dividend Gr. 3/5Y- -
Payout0.00%
Employees806
IPOMar 17, 1980

Ratios

P/E13.44
Forward P/E11.57
PEG-
P/S0.39
P/B1.11
P/C2.12
P/FCF18.02
EV/EBITDA3.13
EV/Sales0.25
Quick Ratio1.59
Current Ratio2.56
Debt/Eq0.12
LT Debt/Eq0.10
Option/ShortYes / Yes

Earnings

EPS (ttm)0.81
EPS next Y0.94
EPS next Q0.13
EPS this Y-38.10%
EPS next Y21.15%
EPS next 5Y-8.98%
EPS past 3/5Y- -0.22%
Sales past 3/5Y4.40% 4.50%
EPS Y/Y TTM0.20%
Sales Y/Y TTM1.21%
EPS Q/Q-64.23%
Sales Q/Q-9.14%
EarningsNov 04 AMC
EPS/Sales Surpr.-44.00% -9.97%

Ownership

Insider Own6.16%
Insider Trans64.20%
Inst Own94.33%
Inst Trans5.07%
ROA5.50%
ROE8.82%
ROIC7.79%
Gross Margin70.34%
Oper. Margin5.34%
Profit Margin3.05%
SMA20-9.53%
SMA50-13.85%
SMA200-45.66%
Trades-

Technical

Shs Outstand17.39M
Shs Float16.26M
Short Float6.53%
Short Ratio6.07
Short Interest1.06M
52W High28.14 -61.16%
52W Low9.38 16.58%
Volatility7.57% 4.33%
ATR (14)0.65
RSI (14)35.72
Beta0.83
Rel Volume0.00
Avg Volume174.97K
Volume0

Performance

Perf Week-9.44%
Perf Month-14.00%
Perf Quarter-29.53%
Perf Half Y-51.27%
Perf YTD-49.35%
Perf Year-44.74%
Perf 3Y-35.71%
Perf 5Y-36.42%
Perf 10Y-16.97%
Recom1.00
Target Price16.50
Prev Close10.93
Price10.93
Change %0.00%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
May 07, 2025ResumedDDA DavidsonBuy$19+73.8%
Sep 13, 2024InitiatedCCanaccord GenuityBuy$18+64.7%
Oct 15, 2021InitiatedDDA DavidsonBuy$22+101.3%
Apr 09, 2015InitiatedIImperial CapitalIn-line$15+37.2%
Jun 02, 2014InitiatedSSingular ResearchBuy$20+83.0%
Mar 08, 2013ReiteratedIImperial CapitalIn-line$17 → $15+37.2%

Peers

Mkt cap
TickerCompanyMkt cap
USNAUsana Health Sciences Inc242.22M
HLFHerbalife Ltd1.64B
LFVNLifevantage Corp57.83M
NUSNu Skin Enterprises Inc199.58M
NAIINatural Alternatives International Inc6.27M
MTEXMannatech Inc16.52M
SMPLSimply Good Foods Co1.10B
MEDMedifast Inc145.71M
NHTCNatural Health Trends Corp6.20M
HLNHaleon plc ADR39.56B

Insider trading

latest 14 of 35
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerNov 05 '26Buy9.77291,6662,849,8112,236,152Nov 09 05:21 PM
Yates Bryant JEVP & President, EuropeNov 04 '26Option Exercise0.002,804079,897Nov 06 07:27 PM
Norman Daniel CEVP & President, AsiaNov 04 '26Option Exercise0.002,804049,727Nov 06 07:27 PM
Brower Nathan GEVP, General CounselNov 04 '26Option Exercise0.002,308045,455Nov 06 07:27 PM
Lanoy Jonathan DavidSVP, Chief Accounting OfficerNov 04 '26Option Exercise0.001,277056,812Nov 06 07:26 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 17 '26Buy14.6920,000293,8001,944,486Aug 19 04:42 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 07 '26Buy16.6396,0001,596,5801,883,610Aug 10 07:15 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 10 '26Buy15.8440,876647,5391,924,486Aug 10 07:15 PM
PRESCOTT GROUP CAPITAL MANAGEM10% OwnerAug 06 '26Buy16.574,51374,7931,787,610Aug 10 07:15 PM
Herbert Kevin R.EVP & President, North AmericaJun 12 '26Sale20.682,00041,36448,866Jun 15 06:04 PM
Yates Bryant JEVP & President, EuropeJun 05 '26Sale19.9011,968238,16377,446Jun 11 07:28 PM
Norman Daniel CEVP & President, AsiaJun 01 '26Sale20.649,713200,47647,276Jun 03 06:44 PM
Brower Nathan GEVP, General CounselMay 21 '26Sale21.8412,015262,40843,438May 22 11:59 AM
Brower Nathan GEVP, General CounselMay 05 '26Option Exercise0.005,775046,893May 07 05:29 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
DFSVUS Small Cap Value Portfolio ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
VDCVanguard Consumer Staples ETFAUM: 8.36B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
DFMCU.S. Micro Cap Portfolio ETF Class Shares-
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 206
  • Nature's Sunshine (NATR) Posts First Sales Decline Under New CEO As China Collapses, Digital Stalls And Guidance Is Cut Again (Earnings Whispers) +6.38% -20.09%
  • Nature's Sunshine: Q3 Earnings Snapshot (Associated Press)
  • Nature's Sunshine Reports Third Quarter 2026 Results (GlobeNewswire)
  • Nature's Sunshine Sets Third Quarter 2026 Conference Call for Wednesday, November 4, 2026, at 5:00 p.m. ET (GlobeNewswire)
  • Natures Sunshine Products Inc (NATR) (Q2 2026) Earnings Call Highlights: Record Sales and ... (GuruFocus.com) -19.47%
  • Loading…
  • Nature's Sunshine: Q2 Earnings Snapshot (Associated Press)
  • Nature's Sunshine Reports Second Quarter 2026 Results (GlobeNewswire)
  • Nature's Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer (GlobeNewswire)
  • Earnings To Watch: Natures Sunshine Products Inc (NATR) Reports Q2 2026 Result (GuruFocus.com)
  • Nature's Sunshine Appoints Janine Weber as Executive Vice President and President, North America (GlobeNewswire)
  • Nature's Sunshine Sets Second Quarter 2026 Conference Call for Thursday, August 6, 2026, at 5:00 p.m. ET (GlobeNewswire)
  • Nature's Sunshine: Q1 Earnings Snapshot (Associated Press) -6.42%
  • Nature's Sunshine Reports Strong First Quarter 2026 Results (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.1400.2500.110116.6129.512
2026Q22026-08-060.2100.2700.193116.99123.72
2026Q12026-05-070.3000.2050.286122.89122.152
2025Q42026-03-100.3000.1850.229123.81121.52
2025Q32025-11-060.3600.1600.296128.34120.32
2025Q22025-07-310.3500.1600.281114.75112.252
2025Q12025-05-060.2500.1650.252113.25109.32
2024Q42025-03-110.0000.200-0.017118.21109.32
2024Q32024-11-070.2700.1420.230114.62108.942
2024Q22024-08-080.0700.1800.071110.55112.31
2024Q12024-05-070.1200.1700.121111111.21
2023Q42024-03-120.4500.1500.462108.94111.11
2023Q32023-11-070.1500.1300.145111.2110.21
2023Q22023-08-090.1200.0300.123116.55103.51
2023Q12023-05-090.230-0.0100.044108.63101.521
2022Q42023-03-150.100-0.0400.101102.75100.31

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2016FY0.110-0.110--
2018FY0.190--0.045--
2019FY0.340-0.344--
2020FY1.070-1.069--
2021FY1.4100.8201.419444.08435.5
2022FY0.040-0.100-0.020421.91419.4
2023FY0.9500.6500.775445.32447.5
2024FY0.4600.6610.403454.36445.48
2025FY1.2601.1501.060480.14477.82
2026FY-0.780--466.93
2027FY-0.945--479.05
2028FY-0.950--488.2

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-05202110.49110.19110.8
2026Q4S2026-11-04200126.34126.28126.4
2026Q4S2026-10-28200126.34126.28126.4
2026Q4S2026-10-21200126.35126.3126.4
2026Q4S2026-08-07202126.35126.3126.4
2026Q4S2026-05-25200129.24128.48130
2026Q4S2026-05-08220129.24128.48130
2026Q4S2026-05-01220128.85127.7130
2026Q4S2026-04-06220128.85127.7130
2026Q4S2026-03-11220128.85127.7130
2026Q4S2026-03-09200126.55126.1126.99
2026Q4S2026-01-21200126.67126.1127.24
2026Q4S2025-11-11220126.67126.1127.24
2026Q4S2025-11-10220126.67126.1127.24

Estimate history

EPS, annual-0.69-0.0450.3441.0691.419-0.020.7750.4031.0570.8133
Period201720182019202020212022202320242025TTM
EPS, quarterly0.23-0.0170.2520.2810.2960.2290.2860.1930.106
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual342.029364.81362.215385.205444.084421.91445.32454.364480.144480.29
Period201720182019202020212022202320242025TTM
Sales, quarterly114.615118.205113.248114.75128.339123.807122.892116.985116.603
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual18.91919.20419.4119.69719.72419.09318.87518.48317.50817.386
Period201720182019202020212022202320242025MRQ
Shares, quarterly18.49818.48318.47417.63517.5617.50817.56417.61417.386
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue480.29480.14454.36445.32421.91444.08385.20362.21364.81
Cost of Goods Sold Incl. D&A142.44146.26143.90136.01133.18126.63112.0293.9495.69
Gross Profit337.85333.88310.47309.31288.74317.45273.19268.27269.12
Selling, General and Administrative Excl. Other312.22309.14290.37284.86272.48282.37250.90249.75262.27
Research and Development-1.901.701.601.501.401.502.102.80
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income25.6324.7420.0924.4516.2635.0922.2918.526.85
Interest Expense0.140.100.150.070.250.250.100.040.39
Unusual Expense0.000.000.005.700.000.420.812.401.50
Net Income Before Taxes24.3829.8118.4320.2015.2131.8222.8215.643.20
Income Taxes9.329.3610.533.7914.661.61-0.148.714.40
Consolidated Net Income15.0620.457.8916.420.5530.2122.966.93-1.20
Net Income From Continuing Operations14.6519.527.7015.08-0.3928.8521.346.76-0.85
Net Income14.6519.527.7015.08-0.3928.8521.346.76-0.85
EPS (Recurring)0.821.060.400.98-0.021.431.100.430.01
EPS (Basic, Before Extraordinaries)0.831.080.410.79-0.021.451.090.35-0.04
EPS (Diluted)0.811.060.400.77-0.021.421.070.34-0.04
EBITDA38.6738.5934.3136.2731.9451.6037.7734.5216.75
Non-Operating Income (Expense)-1.115.17-1.521.52-0.79-2.601.44-0.44-1.76
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.644.573.783.872.292.722.761.551.50
Price To Earnings Ratio13.4413.4416.5941.8215.1712.9913.1724.53-
Price To Sales Ratio0.470.830.620.760.380.850.770.480.43
Gross Margin70.3469.5468.3369.4668.4471.4970.9274.0773.77
Operating Margin5.345.154.425.493.857.905.795.111.88
Net Margin3.054.071.693.39-0.096.505.541.87-0.23
Shares Outstanding17.3917.5118.4818.8819.0919.7219.7019.4119.20
Market Capitalization189.40189.40270.85329.81159.47365.57278.33163.49148.23

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue116.60116.98122.89123.81128.34114.75113.25118.20
Cost of Goods Sold Incl. D&A34.8534.1136.1437.3337.8335.9535.1537.16
Gross Profit81.7582.8786.7586.4790.5178.8078.1081.04
Selling, General and Administrative Excl. Other76.4777.3977.2181.1581.5374.5371.9376.49
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income5.285.489.545.328.974.276.174.55
Interest Expense0.030.050.040.030.030.020.020.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes5.375.378.155.499.677.547.111.45
Income Taxes3.481.833.040.974.142.022.232.18
Consolidated Net Income1.893.545.124.515.545.524.88-0.73
Net Income From Continuing Operations1.893.545.124.115.335.334.75-0.32
Net Income1.893.545.124.115.335.334.75-0.32
EPS (Recurring)0.110.190.290.230.300.280.25-0.02
EPS (Basic, Before Extraordinaries)0.110.200.290.230.300.290.26-0.02
EPS (Diluted)0.110.190.290.230.300.280.25-0.02
EBITDA8.498.7812.778.6312.517.779.678.57
Non-Operating Income (Expense)0.12-0.06-1.350.190.723.290.96-3.10
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.541.571.291.231.021.291.030.95
Price To Earnings Ratio13.4419.9722.6726.5920.8127.6331.0616.59
Price To Sales Ratio0.470.810.880.810.590.610.520.60
Gross Margin70.1170.8470.5969.8570.5268.6768.9668.56
Operating Margin4.534.697.774.306.993.725.453.85
Net Margin1.623.024.163.324.164.654.19-0.27
Shares Outstanding17.3917.6117.5617.5117.5617.6418.4718.48
Market Capitalization189.40383.35420.01377.56273.70273.07231.97270.85

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments93.8984.7082.3760.0386.1892.0753.6350.6442.91
Short Term Receivables8.609.488.8314.118.877.387.327.758.89
Inventories68.3159.4466.8967.9560.8547.6846.6742.0544.05
Other Current Assets8.046.967.727.428.766.945.096.396.66
Total Current Assets178.84160.58165.82149.51164.67154.06112.70106.83102.51
Net Property, Plant & Equipment50.5252.3858.3662.3169.2174.5683.4664.0669.11
Total Investments and Advances1.130.920.750.700.960.991.151.311.98
Intangible Assets------0.570.620.71
Deferred Tax Assets20.0717.6415.066.8613.598.694.909.068.28
Other Assets10.599.339.7810.4010.4511.1910.2811.1512.61
Total Assets261.15240.85249.77229.78258.87249.50213.07193.02195.19
Short Term Debt Incl. Current Port. of LT Debt3.273.934.555.445.907.506.461.530.51
Accounts Payable8.028.917.916.359.706.494.415.224.21
Income Tax Payable4.704.126.424.122.652.391.393.381.83
Other Current Liabilities62.5448.7457.8849.6858.4253.2845.6956.5647.10
Total Current Liabilities78.5465.6976.7565.5876.6769.6557.9566.6953.66
Long Term Debt15.6310.2810.3813.7417.0918.8320.210.0013.18
Provision for Risks Charges0.730.930.610.510.300.391.502.595.53
Deferred Tax Liabilities0.951.011.401.441.571.391.661.560.77
Other Liabilities3.741.961.091.461.842.002.321.612.32
Total Liabilities99.5979.8690.2382.7397.4792.2683.6372.4575.46
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity161.55155.31154.06142.91158.20155.39129.21120.50119.32
Total Shareholders Equity161.55155.31154.06142.91158.20155.39129.21120.50119.32
Accumulated Minority Interest0.005.685.484.143.201.850.230.060.41
Total Equity161.55160.99159.54147.05161.40157.23129.44120.57119.73
Total Liabilities & Stockholders Equity261.15240.85249.77229.78258.87249.50213.07193.02195.19
Book Value Per Share9.238.408.167.488.027.896.666.276.31
Tangible Book Value Per Share9.238.408.167.488.027.896.636.246.27
Full-Time Employees806819814800850837834905911
Price to Book Ratio1.111.732.251.162.311.791.271.231.52
Return on Assets7.783.146.29-0.1611.359.233.33-0.44-6.46
Return on Equity12.324.9810.15-0.2618.4014.995.42-0.71-10.34
Return on Invested Capital11.024.659.17-0.2516.4612.254.53-0.71-9.77
Quick Ratio1.411.541.291.241.351.531.140.971.09
Current Ratio2.282.442.162.282.152.211.941.601.91

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income15.0620.457.8916.420.5530.2122.966.93-1.20
Depreciation13.0413.8414.2211.8215.6816.5215.4815.999.81
Other Funds (Non Cash)13.276.3913.318.345.196.752.793.031.39
Funds from Operations42.2138.4133.7628.0528.0349.3536.8730.239.98
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-22.57-3.09-8.4613.18-27.32-14.740.79-21.6911.86
Income Taxes Payable-6.16-0.06-2.942.631.43-0.390.67-1.961.30
Cash from Operating Activities19.6435.3225.3041.230.7134.6137.668.5421.83
Capital Expenditures-9.13-6.48-10.97-10.48-7.63-6.67-4.91-5.10-4.83
Net Assets From Acquisitions-6.16-6.160.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.050.000.005.04
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-15.29-12.64-10.97-10.48-7.63-6.61-4.91-5.100.21
Cash Dividends Paid0.000.000.000.000.00-19.860.000.000.00
Change in Capital Stock-8.03-16.31-8.86-6.40-13.57-9.660.470.260.66
Repurchase of Common Pref Stock-8.03-16.31-8.86-6.40-13.57-7.420.000.000.00
Sale of Common Pref Stock0.000.000.000.000.00-2.230.470.260.66
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.00-1.17-1.55-2.203.410.00-12.18
Change in Long Term Debt0.000.000.00-1.17-1.24-1.31-5.370.00-13.18
Issuance of Long Term Debt34.205.0940.9916.2945.010.000.002.0668.32
Reduction of Long Term Debt-34.20-5.09-40.99-17.47-46.25-1.31-5.37-2.06-81.50
Net Financing Active Other Cash Flow-2.93-1.30-1.05-0.39-1.130.000.00-0.32-0.68
Other Financing Activities Uses-2.93-1.30-1.05-0.39-1.130.000.00-0.32-0.68
Cash from Financing Activities-10.96-17.61-9.90-7.96-16.25-31.723.88-0.06-12.19
Exchange Rate Effect0.444.12-2.10-0.45-2.99-2.161.81-0.39-2.12
Net Change in Cash-6.189.192.3322.34-26.15-5.8838.442.997.73
Free Cash Flow10.5128.8414.3330.75-6.9227.9432.753.4417.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow21.5813.8219.5310.95-46.529.1151.039.17
Deferred Taxes & Investment Tax Credit--2.27-1.66-8.536.60-4.13-4.364.28-0.02

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments89.3882.5087.5893.8995.5581.34
Short Term Receivables18.3213.8612.558.6015.1113.03
Inventories71.2971.7367.1368.3167.3369.32
Other Current Assets9.3910.3011.338.048.088.14
Total Current Assets188.38178.40178.59178.84186.08171.84
Net Property, Plant & Equipment48.7250.2451.7950.5246.9450.15
Total Investments and Advances1.231.251.271.131.111.04
Deferred Tax Assets19.3319.5019.4120.0720.3621.41
Other Assets10.5710.4410.4010.5910.3210.44
Total Assets268.23259.82261.46261.15264.81254.88
Short Term Debt Incl. Current Port. of LT Debt4.574.424.373.274.604.62
Accounts Payable8.157.738.258.027.129.92
Income Tax Payable1.583.504.974.707.605.76
Other Current Liabilities59.1953.0953.7862.5464.3355.54
Total Current Liabilities73.4968.7571.3778.5483.6575.85
Long Term Debt16.4617.0018.0615.639.6911.01
Provision for Risks Charges1.750.110.430.730.440.64
Deferred Tax Liabilities1.070.890.800.951.071.01
Other Liabilities3.793.773.883.743.252.69
Total Liabilities96.5590.5194.5499.5998.1091.19
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity171.68169.32166.92161.55160.50157.68
Total Shareholders Equity171.68169.32166.92161.55160.50157.68
Accumulated Minority Interest0.000.000.000.006.206.00
Total Equity171.68169.32166.92161.55166.70163.68
Total Liabilities & Stockholders Equity268.23259.82261.46261.15264.81254.88
Book Value Per Share9.879.619.509.239.148.94
Tangible Book Value Per Share9.879.619.509.239.148.94
Full-Time Employees---806--
Price to Book Ratio1.112.292.602.361.741.69
Return on Assets5.507.037.747.785.925.75
Return on Equity8.8211.0712.1212.329.529.15
Return on Invested Capital1.001.902.772.323.133.16
Quick Ratio1.591.551.561.411.421.35
Current Ratio2.562.602.502.282.222.27

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income1.893.545.124.515.545.52
Depreciation3.213.303.223.313.543.50
Other Funds (Non Cash)2.983.333.933.021.66-0.29
Funds from Operations8.4510.1412.9510.6711.817.53
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.30-9.31-14.80-0.776.66-3.19
Income Taxes Payable-1.97-1.440.13-2.871.99-1.46
Cash from Operating Activities10.750.84-1.859.9018.474.34
Capital Expenditures-1.54-2.78-2.48-2.34-1.68-1.35
Net Assets From Acquisitions0.000.000.00-6.160.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-1.54-2.78-2.48-8.50-1.68-1.35
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-3.53-2.06-0.50-1.93-2.02-11.88
Repurchase of Common Pref Stock-3.53-2.06-0.50-1.93-2.02-11.88
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.0019.3111.623.260.001.09
Reduction of Long Term Debt0.00-19.31-11.62-3.260.00-1.09
Net Financing Active Other Cash Flow-0.03-1.39-1.08-0.43-0.37-0.24
Other Financing Activities Uses-0.03-1.39-1.08-0.43-0.37-0.24
Cash from Financing Activities-3.56-3.46-1.58-2.36-2.40-12.12
Exchange Rate Effect1.220.32-0.41-0.70-0.193.99
Net Change in Cash6.87-5.08-6.31-1.6614.21-5.14
Free Cash Flow9.21-1.94-4.337.5616.792.99
Price to Free Cash Flow21.5822.1018.6913.418.9512.54

Revenue breakdown

Cardiovascular Products2024: 81.70M 2025: 81.64M
Digestive Products2024: 111.74M 2025: 124.37M
General Health Products2024: 183.88M 2025: 192.12M
Immunity Products2024: 38.72M 2025: 40.82M
Personal Care Products2024: 17.80M 2025: 23.27M
Weight Management Products2024: 20.51M 2025: 17.93M
Japan2024: 43.94M 2025: 56.07M
Other countries2024: 160.56M 2025: 172.57M
South Korea2024: 51.36M 2025: 50.84M
Taiwan2024: 70.58M 2025: 67.28M
United States2024: 127.92M 2025: 133.39M
Asia2024: 207.79M 2025: 221.78M
Europe2024: 84.84M 2025: 93.13M
Latin America and other2024: 22.88M 2025: 21.62M
North America2024: 138.85M 2025: 143.61M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.53%1.1M16.3M159.27K
2026-10-155.56%0.9M16.5M160.54K
2026-09-305.19%0.9M16.5M159.34K
2026-09-155.02%0.8M16.5M166.10K
2026-08-314.85%0.8M16.6M167.26K
2026-08-143.28%0.5M16.6M151.74K
2026-07-313.04%0.5M16.6M122.92K
2026-07-153.05%0.5M16.6M117.58K
2026-06-303.77%0.6M16.6M115.01K
2026-06-153.52%0.6M16.6M113.22K
2026-05-292.07%0.3M16.6M111.78K
2026-05-151.79%0.3M16.6M109.02K
2026-04-301.67%0.3M16.1M122.19K
2026-04-151.40%0.2M16.0M132.00K
2026-03-311.54%0.2M16.0M131.36K
2026-03-131.46%0.2M16.0M124.94K
2026-02-271.29%0.2M16.0M117.55K
2026-02-131.43%0.2M16.0M119.11K
2026-01-301.22%0.2M16.0M130.52K
2026-01-151.00%0.2M16.0M121.11K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.000.00-0.000.00---
call5.000.000.000.00-0.000.00---
call7.500.000.000.00-0.000.00---
call10.000.000.000.40-1.000.00---
call12.500.000.000.00-0.000.00---
call15.000.000.000.05-2.000.00---
call17.500.000.000.00-0.000.00---
call20.000.000.002.93-3.000.00---
call22.500.000.000.55-2.000.00---
call25.000.000.001.50-19.000.00---
call30.000.000.000.76-20.000.00---
call35.000.000.001.15-1.000.00---
put2.500.000.000.00-0.000.00---
put5.000.000.000.00-0.000.00---
put7.500.000.000.00-0.000.00---
put10.000.000.000.05-1.000.00---
put12.500.000.001.09-1230.00---
put15.000.000.003.00-2.000.00---
put17.500.000.000.65-3.000.00---
put20.000.000.003.00-3.000.00---
put22.500.000.002.30-1.000.00---
put25.000.000.003.80-0.000.00---
put30.000.000.005.00-0.000.00---
put35.000.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-27SCHEDULE 13G/ASEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-143Initial statement of beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-10SCHEDULE 13G/ASEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-21SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-112.85M100
2026-100000
2026-090000
2026-082.61M400
2026-070000
2026-0600480.00K3
2026-0500262.41K1
2026-040000
2026-0300951.21K3
2026-020000
2026-010000
2025-120037.89K1
2025-1100363.09K3

Institutional holders

Manager% owned
WYNNEFIELD CAPITAL INC14.07%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.11.05%
DIMENSIONAL FUND ADVISORS LP5.72%
BlackRock, Inc.5.62%
AMERICAN CENTURY COMPANIES INC4.07%
KENNEDY CAPITAL MANAGEMENT LLC3.55%
VANGUARD CAPITAL MANAGEMENT LLC3.44%
ACADIAN ASSET MANAGEMENT LLC3.38%
RENAISSANCE TECHNOLOGIES LLC3.00%
Boston Partners2.18%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF3.89%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.40%
iShares Russell 2000 ETF2.23%
Boston Partners Small Cap Value Fund II (R6)1.07%
College Retirement Equities Fund - Total Global Stock Account1.02%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
VANGUARD CONSUMER STAPLES INDEX FUND0.94%
Fidelity Small Cap Index Fund0.90%
U.S. Targeted Value Portfolio0.74%
U.S. SMALL CAP VALUE PORTFOLIO0.68%

OakChart. NATR. Cached 15 minutes.